The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women
Authors:
- A. Ben-ArieABA. Ben-Arie
- M. HuszarMHM. Huszar
- N. Ben-ZviNBN. Ben-Zvi
- A. SmirnovASA. Smirnov
- P. AltevogtPAP. Altevogt
- M. FogelMFM. Fogel
- 1 July 2008
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 34 (7) , 795-799
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy☆Human Pathology, 2006
- Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year periodInternational Journal of Gynecological Cancer, 2006
- Diagnostic strategies for unknown primary cancerCancer, 2004
- Diagnostic and therapeutic management of cancer of an unknown primaryEuropean Journal of Cancer, 2003
- L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomasThe Lancet, 2003
- Cancer from an Unknown Primary SiteThe American Journal of the Medical Sciences, 2003
- Cancer of unknown primary: biological and clinical characteristicsAnnals of Oncology, 2003
- Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992European Journal of Cancer, 2002
- Cancer of unknown primary siteCancer, 1995
- Carcinoma of unknown primary: Identification of a treatable subset?Annals of Oncology, 1990